The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

This study investigates plasma metabolites to clarify the relationship between these metabolites and breast cancer, aiming to identify valuable biomarkers. Furthermore, by incorporating clinical information-such as cancer stage, type, treatment outcomes, and prognosis-into prospective studies, the research seeks to further examine the correlation between plasma metabolites, treatment efficacy, and prognosis.

NCT Number	NCT06698679
Lead Sponsor	Shengjing Hospital
Conditions	Breast Cancer
Enrollment	1,000 participants
Start Date	2024-11-15
Primary Completion	2031-06-30 (estimated)
Study Completion	2031-10-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-21